Ghent University Academic Bibliography

Advanced

Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis

Philippe Carron UGent, Bieke Lambert UGent, Liesbet Van Praet, Filip De Vos UGent, Gaëlle Varkas UGent, Lennart Jans UGent, Dirk Elewaut UGent and Filip Van den Bosch UGent (2016) RMD OPEN. 2(1).
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
RMD OPEN
RMD Open
volume
2
issue
1
article number
e000265
pages
11 pages
ISSN
2056-5933
DOI
10.1136/rmdopen-2016-000265
language
English
UGent publication?
yes
classification
A2
copyright statement
Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
id
8502197
handle
http://hdl.handle.net/1854/LU-8502197
date created
2017-01-16 10:33:50
date last changed
2017-02-28 12:27:14
@article{8502197,
  articleno    = {e000265},
  author       = {Carron, Philippe and Lambert, Bieke and Van Praet, Liesbet and De Vos, Filip and Varkas, Ga{\"e}lle and Jans, Lennart and Elewaut, Dirk and Van den Bosch, Filip},
  issn         = {2056-5933},
  journal      = {RMD OPEN},
  language     = {eng},
  number       = {1},
  pages        = {11},
  title        = {Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis},
  url          = {http://dx.doi.org/10.1136/rmdopen-2016-000265},
  volume       = {2},
  year         = {2016},
}

Chicago
Carron, Philippe, Bieke Lambert, Liesbet Van Praet, Filip De Vos, Gaëlle Varkas, Lennart Jans, Dirk Elewaut, and Filip Van den Bosch. 2016. “Scintigraphic Detection of TNF-driven Inflammation by Radiolabelled Certolizumab Pegol in Patients with Rheumatoid Arthritis and Spondyloarthritis.” Rmd Open 2 (1).
APA
Carron, P., Lambert, B., Van Praet, L., De Vos, F., Varkas, G., Jans, L., Elewaut, D., et al. (2016). Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis. RMD OPEN, 2(1).
Vancouver
1.
Carron P, Lambert B, Van Praet L, De Vos F, Varkas G, Jans L, et al. Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis. RMD OPEN. 2016;2(1).
MLA
Carron, Philippe, Bieke Lambert, Liesbet Van Praet, et al. “Scintigraphic Detection of TNF-driven Inflammation by Radiolabelled Certolizumab Pegol in Patients with Rheumatoid Arthritis and Spondyloarthritis.” RMD OPEN 2.1 (2016): n. pag. Print.